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Background and purpose: Radiotherapy requires tight control of the delivered dose. This should include the
variation in beam output as this may directly aﬀect treatment outcomes. This work provides results from a multi-
centre analysis of routine beam output measurements.
Materials and methods: A request for 6MV beam output data was submitted to all radiotherapy centres in the UK,
covering the period January 2015–July 2015. An analysis of the received data was performed, grouping the data
by manufacturer, machine age, and recording method to quantify any observed diﬀerences. Trends in beam
output drift over time were assessed as well as inter-centre variability. Annual trends were calculated by linear
extrapolation of the ﬁtted data.
Results: Data was received from 204 treatment machines across 52 centres. Results were normally distributed
with mean of 0.0% (percentage deviation from initial calibration) and a 0.8% standard deviation, with 98.1% of
results within ±2%. There were eight centres relying solely on paper records. Annual trends varied greatly
between machines with a mean drift of +0.9%/year with 95th percentiles of +5.1%/year and−2.2%/year. For
the machines of known age 25% were over ten years old, however there was no signiﬁcant diﬀerences observed
with machine age.
Conclusions: Machine beam output measurements were largely within ±2% of 1.00 cGy/MU. Clear trends in
measured output over time were seen, with some machines having large drifts which would result in additional
burden to maintain within acceptable tolerances. This work may act as a baseline for future comparison of beam
output measurements.
1. Introduction
Radiotherapy machines are calibrated to deliver a known dose
under a set of standard conditions. During treatment, the dose delivered
to the patient must be tightly controlled. There are Codes of Practice
[1–7] which are provided by various standards laboratories which all
centres should follow. These give details on implementing a traceable
calibration chain to the primary standard, which in turn is inter-com-
pared with others around the world [8]. Following the initial calibra-
tion, the beam output is monitored to ensure consistent and accurate
dose delivery. This ongoing monitoring forms part of a larger quality
assurance (QA) programme, however the frequency of testing is known
to vary between diﬀerent centres [9]. Often a ‘consistency device’ is
used on a daily basis [10] with a measurement performed by a traceable
ionisation chamber less frequently. Tolerances used for these beam
output measurements can also vary between centres, with tolerances
for daily measurements using a consistency device ranging
between± 1% and±5% [9]. Recommended tolerances for daily
output constancy and monthly calibration checks are typically± 5%
and±2% respectively [10–12].
The variation in delivered dose will have a direct clinical impact on
the patient and a number of factors contribute to the overall dose
variation [13,14]. Treatment techniques have advanced such as with
the introduction of Intensity Modulated Radiotherapy (IMRT) and now
with the growing use of automated planning techniques, planning is
becoming more consistent [15,16]. However, the variation in dose due
to the allowable range of beam output has largely remained unchanged
with many centres using a±2% tolerance on the allowable beam
output [9]. Audit programmes are in place which assess the accuracy of
the beam calibration. These audits include those as part of clinical
trials, regional audits and national audits [17], with beam output audits
commonplace worldwide [18,19]. The consistency of the implementa-
tion and maintenance of absolute beam calibrations has been shown to
be either consistent or to improve over time [20]. However, no large
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study of the routine local beam output measurements across multiple
centres has been conducted, and this variation from the initial cali-
bration may have a similar signiﬁcance in overall dose variation.
Previous work examining the variation in beam output data over
time has focussed on an individual centres treatment machines [21,22],
whereas this work aims to give a broad representation of the multi-
centre variation in machine beam output measurements. The presence
of trends over time, variation between measurement devices, and re-
cording methods were investigated. Through tighter control of beam
output, the variation in patient outcomes could be reduced. This work
acts as a benchmark for the current variation in dose due to variations
in beam output.
2. Materials and methods
2.1. Data collection and formatting
A request for data was sent by email to all UK radiotherapy centres
through the regional audit network [23]. The data requested was for
6MV beam output data covering the 6month period from January 2015
to June 2015. This time period was chosen as a balance between being a
manageable dataset for centres to collate, and being representative of
variations in measurements seen over time. Data requested included;
treatment machine model, machine install date, measurement device,
data recording method, and measured beam output. A quantitative
statistical analysis of the data was performed to evaluate the variations
which exist in measurement of beam output. Statistics including the
mean output were calculated for each treatment machine allowing
comparison of delivered dose across centres and within the same centre.
The Radiotherapy Services in England 2012 report [24] states that there
were 265 linacs in use across 58 centres. Based on this we estimate
there was approximately 300 linacs in operation at the time of data
collection for this work.
For the purposes of this work, the data was collated and formatted
so that beam output was represented as a percentage deviation from
initial calibration. For example, a beam considered not to have changed
from initial calibration would have an output of 0%, whereas one which
delivers 2% greater dose relative to that at calibration would have a
beam output of +2%. To remove outliers, a tolerance of± 5% was
used, as centres would generally not continue treatment if output de-
viated to this extent [9], and a majority of these values are actually
erroneous results as stated by the centres during submission. In total 59
data points (0.22%) were removed from the dataset (53 of these were
over 10% and were most often accompanied by repeat measurements
which were within the normal range, thus indicating erroneous results),
leaving a total of 24,501 measured beam outputs to be included in the
analysis.
2.2. Data analysis
The centres were designated as small, medium or large based on the
lower and upper quartiles of the total number of centres housing a
particular number of treatment machines. This resulted in approxi-
mately even sized groups ensuring meaningful comparisons could be
made. A small centre contained 2 or fewer, medium had 3 or 4, and a
large centre had 5 or more machines. This resulted in 20 small, 13
medium and 19 large centres. For the purposes of this work satellite
centres were treated separately from their parent centre. It was found
that there was no signiﬁcant diﬀerence observed between data from
centres of diﬀering size, and so no results split by centre size are pre-
sented. A breakdown of the distribution of centre size is given in the
supplementary material S1.
It is known that the beam output will tend to drift over time, often at
diﬀering rates dependant on the age of the installed in-head ionisation
chamber. The observed variation in beam output over the six month
period was assessed for each treatment machine and results were
linearly extrapolated to give the annual trend. The results have then
been grouped by manufacturer and treatment machine age (in-head
ionisation chamber age was generally not known for this dataset).
In many cases it was observed that a treatment machine or mea-
surement device had been recalibrated which was clear from step
changes present in the data (see Fig. 2 for an example), and so this
calibration jump was removed to allow a more robust analysis of the
trends over the data span of 6months. The data was corrected by
subtracting the magnitude of the identiﬁed step change from all sub-
sequent data. Removal of this step change aims to remove this ambi-
guity within the data and give a truer representation of the overall drift
in beam output. Where appropriate results were separated by treatment
machine manufacturer to assess the diﬀering technologies used by each.
Results presented are from data which was normally distributed and so
comparison was performed by means of a t-test where appropriate.
When repeated t-tests were performed a Benferroni correction was used
to adjust for multiple comparisons.
Data was received in a variety of formats including paper records
(scanned or manually transcribed), database systems (in-house or
commercial) and spreadsheets, with many centres using a mix of re-
cording techniques. A common method was to transcribe paper records
into an electronic system to allow trend visualisation and additional
analysis. There were eight centres which solely relied upon paper re-
cords for beam output checks. A breakdown of the recording methods
used for diﬀerent sized centres is given within the supplementary ma-
terial S2.
The oldest machine at the time of data collection (2015) was
16 years old (installed in 1999). The age of machines in the dataset is
given in Supplementary material S3 giving a breakdown by manu-
facturer. The optimal lifespan of treatment machines is generally con-
sidered to be 10 years [25,26] and so data was assessed to identify any
variation with machine age.
Where data was supplied for both constancy device measurements
and ionisation chamber measurements the mean output as measured by
each of these devices has been compared for each machine.
3. Results
Data was received from 52 centres, and included 204 treatment
machines. A breakdown by manufacturer is given in Table 1. The install
date was provided for 187 treatment machines, 47 of which were older
than 10 years. Detail of machine install year is given in supplementary
material S3.
The data included 41 National Health Service (NHS) centres (190
treatment machines) and 11 privately funded radiotherapy centres (14
treatment machines). Measurement frequency varied between daily and
monthly and most commonly results were recorded in a mix of paper
based and electronic formats (a breakdown of recording method by
with centre size is given in supplementary material 2).
A variety of constancy devices were reported in use, which range
from those having a single ionisation chamber or diode, to those with
Table 1
Summary of ﬁtted linear trends of beam output over time for each manufacturer after
correction for calibrations. There was no statistically signiﬁcant diﬀerence observed be-
tween manufacturers at the 95% level (p > .05).
Manufacturer Number of
machines
Mean trend
(%/year)
Median trend
(%/year)
Trend standard
deviation
(%/year)
Varian 96 1.22 0.78 2.27
Elekta 92 0.71 0.44 2.03
Siemens 12 −0.06 0.98 3.31
Tomotherapy 3 0.72 −0.26 2.11
CyberKnife 1 −1.06 −1.06 N/A
All 204 0.89 0.56 2.27
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arrays of measurement points which are also capable of measuring
additional aspects of the beam such as energy, symmetry and ﬂatness.
There are now also implementations using the treatment machines
imaging panel which allow checks of multiple aspects of the beam and
these are also included within the dataset.
The measurements were normally distributed with a mean of 0.0%
and a standard deviation of 0.8%. This distribution of measured ma-
chine output is given in Fig. 1.
The number of beam output measurements exceeding a±1% was
5947 (24.3%) with 47 (1.9%) exceeding±2% and 45 (0.2%) ex-
ceeding±3%.
3.1. Trends in beam output
Within this 6month data set 35 treatment machines were seen to
have a single calibration and 7 treatment machines had two calibrations
performed during this period. Fig. 2 shows a typical set of output
measurements from a single machine with daily and monthly mea-
surements taken using diﬀerent measurement devices. In this case the
daily and monthly measurements are considered well matched with less
than 0.5% diﬀerence in mean results between the measurement de-
vices. In Fig. 2 key aspects of beam output measurements are observed.
A period of upward trend between March 2015 and June 2015 is seen
followed by a calibration.
The overall observed trend in beam output drift for all treatment
machines was +0.9%/year. The 95th percentile was +5.1% and 5th
percentile was −2.2% indicating the large inter treatment machine
variation possible.
No signiﬁcant diﬀerence was seen at the 95% level (p > .05) be-
tween the beam output trends of diﬀerent manufacturers. A summary
for each manufacturer is presented in Table 1.
3.2. Mean machine output
The mean output for individual machines ranged between a max-
imum of +1.6% and a minimum of −2.1% with an overall mean of
0.0%. The 5th and 95th percentiles were −1.1% and +0.9% respec-
tively. Within a single centre the greatest diﬀerence in mean output was
2.2% (range −0.7% to +1.5%). The values for this centre are high-
lighted in Fig. 3 which shows the mean output for each machine. In the
case of the highlighted centre in Fig. 3 two diﬀerent types of constancy
device were used across the machines, however there was no statisti-
cally signiﬁcant diﬀerence between measurements made with the de-
vices when compared with ionisation chamber measurements. An intra-
centre variation of> 2% was observed for 4 of the 52 centres (7.6%),
and a variation of> 1% for 23 centres (44.2%). The mean intra-centre
variation was 0.87%.
3.3. Variation between measurement devices
Of the 204 machines, 99 provided data for measurements taken
with ionisation chambers (used weekly or monthly) and with a separate
consistency device (used daily).
On ﬁve machines (not all within the same centre) the mean diﬀer-
ence in measured output between the consistency device and ionisation
chamber measurements was> 1% and 28 exceeded 0.5%. All but one
of these was deemed statistically signiﬁcant (p > .05).
There has been no observed statistically signiﬁcant diﬀerence of
measurement consistency between diﬀerent measurement devices
across the machines.
Fig. 1. Distribution of measured machine output. Data has a mean of 0.0%, with a
standard deviation of 0.8%. There are 75.7% of measurements within± 1%.
Fig. 2. Typical set of beam output data showing weekly Farmer chamber and daily
Linacheck measurements for a single linac. This dataset includes a period of upward trend
from March 2015 to June 2015 followed by a calibration.
Fig. 3. Plot showing the mean output from each treatment machine over the data col-
lection period plotted in order of mean beam output. The machines from the centre with
the greatest intra-centre variation are highlighted and have a range of 2.2% (range
0.7–1.5%). These machines showed no statistically signiﬁcant diﬀerence between mea-
surement devices used (p > .05) and in the case of the highlighted machine two separate
types of constancy device were in use.
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4. Discussion
This work contains the ﬁrst analysis of local beam output mea-
surements from multiple centres which is in contrast to previous studies
based within a single centre [21,27,28]. The mean output of each
machine within a centre was assessed to give an indication of the
overall variation in delivered dose due to beam output to patients
within that centre (Section 3.2). This indicated diﬀerences in delivered
dose of over 2% are possible due to beam output alone. The variation of
measurements taken with diﬀerent devices on the same machines was
examined. While most had good agreement, there were some which had
diﬀerences in the mean measured value of over 1% in which case it
would be recommended to recalibrate the constancy device to better
match the ionisation chamber measurements if possible.
Obtaining the data from the centres was often troublesome, either
due to resource implications, or due to systems not being able to export
the required data. With a continual drive to modernise services, to in-
troduce collaborative networks between centres and move records to an
electronic format this study has highlighted the importance of the in-
itial stages of implementing an electronic QA system including full
commissioning of all documented features including access to data at a
later date.
It is known that measurement practice varies between centres [9],
however in one case a centre stated that when taking beam output
measurements during their morning run-ups they had an asymmetric
tolerance of−2% to +1%. The reason given was that the beam output
would increase through the day, and so when their high dose treat-
ments were delivered (usually in the afternoon) the beam output would
be closer to the calibration value (with the eﬀective tolerance shifting
to± 1.5%). This highlights the variation in practice between centres.
Comparing with national recommendations of monthly beam output
checks to be within± 2% [10] there was only 1.9% of all individual
measurements outside of this range within this dataset. A single ma-
chine had a mean measured output outside of this range over the entire
6month data period at −2.1% which was perhaps surprising con-
sidering the national recommendations are to be within±2% for
monthly checks.
There is potential for large intra-centre variation on dose received
by the patient depending only on the treatment machine they are as-
signed to. The largest range within a single centre was 2.2% (see Fig. 3)
which is potentially a signiﬁcant diﬀerence, dependant on patient dose
response.
Whilst many centres were moving towards electronic data storage
methods, eight centres relied fully upon paper records, and so may not
be able to readily quantitatively assess trends within datasets. It is
noted that of the 20 centres with two or fewer treatment machines, only
one of these centres relied solely on paper records for recording beam
output measurements (see supplementary material 2 for more detail on
recording methods). This may be because of the increased ﬂexibility of
small centres to adapt practices and conversely the larger initial burden
of transferring between record keeping systems at larger centres. There
was no signiﬁcant diﬀerence in the output measurements between
centres which relied either solely on paper or electronic records,
however comments were made by clinical staﬀ that historic electronic
records are often easier to access and collate, and when requesting the
data for this study, those with paper records were more reluctant to
provide them due to the potential time burden.
The data received from each centre varied; they provided either all
measurements, or only a subset (such as daily, monthly or weekly) of
these. Diﬀerences in measurement device would result in diﬀering
uncertainties on each individual set of data and it is acknowledged that
this may aﬀect comparisons between machines; however this has not
been quantiﬁed within this work. A comparison of measurements taken
with diﬀerent devices on each machine indicated diﬀerences of over 1%
on some machines; however tolerances for this comparison would be
determined locally and is dependent on a number of factors including
the device used and the frequency of alternative measurement techni-
ques. It has also been noted that the mean of measurements made with
a Farmer chamber was greater than those made with consistency de-
vices on two thirds of machines and this warrants further investigation.
Manufacturers have slightly diﬀerent technology within their
treatment machines, and so there is potential for diﬀerent rates of
change in beam output. For instance, Varian uses a sealed ionisation
chamber whereas the chamber for Elekta is unsealed. It has been noted
through communication with clinical staﬀ that the beam output of a
Varian linac will tend to mirror a change in atmospheric pressure in-
dicating chambers are not completely sealed units. Excluding
CyberKnife (which only had a single machine within the dataset) all
manufacturers showed both positive and negative trends in beam
output drift within their treatment machines. There was no signiﬁcant
diﬀerence (p > .05) in the trends in beam output observed between
machines from diﬀerent manufacturers within this dataset.
A previous study of three Varian linacs by Hossain [21] concluded
an annual trend in output of 2–4%, and this compares reasonably with
that found for the Varian machines in this study of 1.2% (±2.2%)/
year (1 SD). A study by Grattan [27] indicated that the variation may be
model speciﬁc and may vary with age. We found no statistically sig-
niﬁcant diﬀerences with machine age however longer term data would
provide a more robust insight. As not all details of calibrations of ma-
chines and devices were known in this dataset it was not possible to
apply reliable corrections to constancy device measurements and so the
data was used as it was supplied. It is however felt that the large volume
of data will reduce any inﬂuence of mis-calibrated measurement de-
vices to some extent. If a similar study was repeated, it would be ben-
eﬁcial to obtain details of both machine and device calibrations.
As treatment techniques become more precise, particularly with the
increased use of intensity modulated techniques [29] and greater
standardisation, this reduction in planned dose diﬀerences between
patients due to increased consistency between treatment plans (which
may further reduce with the introduction of automated planning
techniques [15,30]) will result in dose variation due to the beam output
becoming of greater overall signiﬁcance.
There is potential for patients treated on diﬀerent machines to ex-
perience diﬀering treatment outcomes if the beam output is not main-
tained within strict limits throughout the duration of their treatment.
This dataset highlights the possible diﬀerences in beam output between
machines over a given time period. This variation directly relates to
delivered dose and so also to patient outcomes [31], further high-
lighting the importance of routine monitoring and maintenance. There
was no major cause for concern when examining the machines included
within this study, and overall they are all closely matched; further
studies could be warranted to investigate the potential clinical impact
of reducing variation in beam output and inﬂuence of use of diﬀerent
measurement devices.
This work presented the range of practices in measurement varia-
tion across diﬀerent centres and gives quantitative results for the var-
iation in beam output on diﬀerent machines within a single centre. The
variation over time of beam output on each machine was quantiﬁed,
and again a large possible variation between machines is observed. This
work may act as a baseline for further work such as investigating the
impact of these variations on the development of QC schedules, and on
clinical outcomes. Whilst considered a routine measurement, control of
beam output should remain a high priority to ensure the high precision
and accuracy required in radiotherapy is met.
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